SecBot SecBot
Insider Buy ·Filed Nov 6, 2026

CVS

CVS HEALTH Corp
BULLISH
Impact 4/10
Horizonweeks Processed10d 9h ago SEC0000064803-26-000112
Insider cluster: 1 insiders, $2.0M total
Actionable Insight ▲ Bullish

The purchase immediately follows a strong earnings beat and guidance raise, reinforcing management confidence. Monitor for additional insider buying in the coming weeks as a further signal.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$85.25
T+0 close · Nov 6, 2026 · via day close
Latest settled
+3.92%
T+5 · $88.59
Vs SPY
+5.61%
α at T+5
Next horizon
T+20
in 21d
  1. T+0 · Nov 9 $85.25entry
  2. T+1 · 7d ago +4.41%α +4.78% · $89.01
  3. T+5 · 19h ago +3.92%α +5.61% · $88.59
  4. T+20 · in 21d Pending
  5. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CVS EVP and Group President Prem S. Shah purchased $2.0M of stock on the open market two days after the company reported Q3 2026 earnings that beat consensus and raised full-year guidance. The buy is a conviction signal from a senior executive following strong results.

Key Financial Metrics

Direction
buying
Total Value
$2.0M
Insiders
1

Key Facts

  • EVP and Group President Prem S. Shah purchased 23,855 shares at $83.895 on 2026-11-06, total $2.0M
  • Purchase was open-market (Form 4 code P), not under a 10b5-1 plan
  • Q3 2026 revenue $108.4B (+5.4% YoY), Adjusted EPS $2.09 vs consensus $1.65
  • Full-year 2026 Adjusted EPS guidance raised to at least $8.20 from $7.90-$8.10
  • Cash flow from operations guidance raised to at least $15.5B from at least $11.5B
  • Health Care Benefits MBR improved 150 bps YoY to 91.3%

Financial Impact

$2.0M open-market purchase by senior executive

insider ownership

Risk Factors

  • Single insider buy, not a cluster; less signal than multiple executives buying
  • Purchase represents ~0.002% of market cap, small relative to company size

Market Snapshot

Exchange
NYSE
Sector
Retail-Drug Stores and Proprietary Stores
Analyst Consensus
88% bullish (32 analysts)

Investment Themes

Consumer & Retail

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
INSIDER-BUY Data (Synthetic)0000064803-26-000112

Track record

25 reports on CVS

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +32.33% at T+60 after the Apr 8, 2026 report. 6 of 8 went positive at some point.

Filters
  1. Nov 13, 20264d ago Court Ruling Neutral 3/10 Entry $90.51 Now $88.59 −2.12% settles Dec 15
  2. Nov 6, 202610d ago Insider Buy Bullish 4/10 Viewing Entry $85.25 Now $88.59 +3.92% settles Dec 8
  3. Nov 4, 202612d ago 8-K Neutral 6/10 Entry $79.96 Now $88.59 +10.79% settles Dec 3
  4. Nov 4, 202612d ago 8-K Bullish 6/10 Entry $79.96 Now $88.59 +10.79% settles Dec 3
  5. Oct 26, 202621d ago Institutional Cluster Neutral 3/10 Entry $92.53 Now $88.59 −4.26% settles Nov 23
  6. Oct 15, 20264w ago Press Release Neutral 2/10 Entry $92.58 to $89.79 Now $88.59 −4.31% ▼ −3.01% −1.11% vs SPY
  7. Sep 30, 20266w ago Press Release Neutral 2/10 Entry $85.20 to $90.33 Now $88.59 +3.98% ▲ +6.02% +5.32% vs SPY
  8. Aug 5, 202614w ago 8-K Bullish 8/10 Entry $99.12 to $97.23 Now $88.59 −10.62% ▼ −1.91% −1.31% vs SPY
  9. Jul 10, 202618w ago Press Release Neutral 2/10 Entry $104.15 to $95.46 Now $88.59 −14.94% ▼ −8.35% −10.77% vs SPY
  10. Jun 29, 202620w ago Court Ruling Bullish 5/10 Entry $103.58 to $107.74 Now $88.59 −14.47% ▲ +4.02% +4.30% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens in 7h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026